CONMED Corp — Director's Dealing 2014

Aug 25, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2014-08-23

Reporting Person: Hartman Curt R (Interim CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-08-23	Common Stock	M	2708	—	Acquired	13708	Direct
2014-08-23	Common Stock	F	1321	$37.62	Disposed	12387	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-23	Rsus (restricted Stock Units)	$0	M	2708	Disposed		Common Stock (2708)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company"), and is subject to the terms and conditions of the Company's 2006 Stock Incentive Plan. Under the terms of Mr. Hartman's offer letter, dated July 22, 2014, in connection with his appointment as Interim CEO, the total number of RSUs granted will vest in 1/12 increments for each month he is employed as Interim CEO, provided that any such RSUs that remain unvested at the end of his employment as Interim CEO will be forfeited.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company"), and is subject to the terms and conditions of the Company's 2006 Stock Incentive Plan. Under the terms of Mr. Hartman's offer letter, dated July 22, 2014, in connection with his appointment as Interim CEO, the total number of RSUs granted will vest in 1/12 increments for each month he is employed as Interim CEO, provided that any such RSUs that remain unvested at the end of his employment as Interim CEO will be forfeited.